AMRN Amarin Corporation plc

16.06
-0.63  -4%
Previous Close 16.69
Open 16.46
Price To Book -69.83
Market Cap 5240190885
Shares 326,288,349
Volume 3,330,060
Short Ratio
Av. Daily Volume 14,054,912

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Data presented at AHA November 10, 2018 noted 26% decrease in risk of death/heart attack.
Vascepa REDUCE-IT outcomes trial
High Triglycerides With Mixed Dyslipidemia

Latest News

  1. Here is What Hedge Funds Think About Amarin Corporation plc (AMRN)
  2. Here's Why Amarin Fell 13.6% in November
  3. Today's Research Reports on Trending Tickers: Amarin Corporation and Agios Pharmaceuticals
  4. Amarin (AMRN) Stock Sinks As Market Gains: What You Should Know
  5. 2 Biotech Stocks Poised for Big Gains in 2019
  6. Today's Research Reports on Trending Tickers: Immunomedics and Amarin
  7. Serious Questions Surround CV Sciences Stock
  8. Market Trends Toward New Normal in Amarin, BioSpecifics Technologies, Cavco Industries, Iconix Brand Group, A-Mark Precious Metals, and Core-Mark Holding — Emerging Consolidated Expectations, Analyst Ratings
  9. Why U.S. Steel, Amarin, and Papa John's International Slumped Today
  10. Why Amarin's Latest News Caused Shares to Crash 13% Today
  11. Stocks making the biggest move premarket: UTX, AAPL, HIBB, NVS, TSLA & more
  12. The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial
  13. Amarin Prices Public Offering of American Depositary Shares
  14. Amarin Announces Proposed Public Offering of American Depositary Shares
  15. A Look at Amarin Corporation’s Stock Performance Year-to-Date
  16. Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Amarin Corporation
  17. Amarin to Present at the Evercore ISI HealthCONx Conference
  18. Today's Research Reports on Trending Tickers: Amarin and Seattle Genetics